Pharmaceutical

Pinnaql Acquires VEG, Broadening Manufacturing Compliance & Quality Services Platform

3 Boomerang Portfolio Company Closes Add-on Acquisition, Expanding the Platform's Capabilities FISHERS, Ind. and GUAYNABO, Puerto Rica, Aug. 6, 2025…

5 months ago

AI in Bioprocessing Today — Accelerate. Predict. Deliver., Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how AI/ML models successfully predict bioprocess performance in intensified fed-batch manufacturing systems. The featured speakers will…

5 months ago

Continuity Biosciences Appoints Josephine Torrente and Joseph DeSimone, PhD to Board of Directors

BRADENTON, Fla., Aug. 6, 2025 /PRNewswire/ -- Continuity Biosciences, a company pioneering next-generation combination product drug delivery, today announced the…

5 months ago

Electromedical Technologies, Inc. (OTC: EMED) Provides Mid-Year Update Highlighting Financial Restructuring, Regulatory Alignment, and Strategic Progress

Electromedical Technologies (OTC: EMED) outlines key financial restructuring milestones, upcoming product updates, and new strategic partnerships to drive sustainable growth…

5 months ago

Modular Medical Announces First Human Use of MODD1 Pump Delivering Insulin

- Use of MODD1 on clinician with Type 1 diabetes- Modular Medical intends to deploy the MODD1 on a larger…

5 months ago

Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis

Change in the primary endpoint of left ventricular (LV) extracellular volume (ECV) showed a notable improvement (p = 0.0538) favouring…

5 months ago

Evotec SE to announce first half-year results 2025 on 13 August 2025

HAMBURG, DE / ACCESS Newswire / August 6, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, Prime Standard, ISIN: DE0005664809,…

5 months ago

Medexus Schedules First Fiscal Quarter 2026 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host…

5 months ago

Cryoport Reports Second Quarter 2025 Financial Results

Second quarter revenue increased 14% year-over-year to $45.5 millionCommercial Cell & Gene Therapy revenue increased 33% year-over-year to $8.7 millionLife…

5 months ago

Ategenos Secures Foundational U.S. Patent for First SmartPatch Platform Targeting $1T+ Medication Non-Adherence Crisis

Only platform enabling real-time detection and intervention for medication non-adherence at community scale CAMBRIDGE, Mass., Aug. 5, 2025 /PRNewswire/ --…

5 months ago